SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.
Mazur PK, Reynoird N, Khatri P, Jansen PW, Wilkinson AW, Liu S, Barbash O, Van Aller GS, Huddleston M, Dhanak D, Tummino PJ, Kruger RG, Garcia BA, Butte AJ, Vermeulen M, Sage J, Gozani O
Nature. 2014 Jun 12;510(7504):283-7. doi: 10.1038/nature13320. Epub 2014 May 21.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 85650 | pMSCV-SMYD3 | retroviral expression of human SMYD3 |
| 85652 | pMSCV-MAP3K2 | retroviral expression of human MAP3K2 |
| 85654 | pSico shSMYD3-C human | expression of shRNA targeting human SMYD3 |
| 85656 | pSico shMAP3K2 human | expression of shRNA targeting human MAP3K2 |
| 85657 | pSico shMAP3K2 mouse | expression of shRNA targeting mouse MAP3K2 |